Document:

Exhibit 4.2

 

NEITHER THE CONVERTIBLE NOTE (THE “NOTE”) NOR
THE SHARES OF COMMON STOCK (THE “SHARES”) ISSUABLE UPON CONVERSION HEREOF HAVE BEEN REGISTERED UNDER THE SECURITIES
ACT OF 1933, AS AMENDED (THE “ACT”). THE NOTE AND THE UNDERLYING SHARES ISSUABLE UPON CONVERSION HEREOF MAY BE REFERRED
TO COLLECTIVELY, AS THE “SECURITIES.” 

 

QUANTUM COMPUTING INC.

 

8% CONVERTIBLE PROMISSORY NOTE

 

Principal Amount: ________________

Original Issuance Date: ________________

 

Quantum Computing, Inc., a Delaware corporation
f/k/a Innovative Beverage Group Holdings, Inc. (the “Company”) with offices located 215
Depot Court, Suite 215, Leesburg, VA 20175, pursuant to the terms and conditions set forth in this Subscription and Investor’s
Representation Agreement (the “Subscription Agreement”), has issued this 8% Convertible Promissory Note (the “Note”
or, collectively, the “Notes”) to ____________ (the “Holder”) this ___ day of ______, 2018 (the “Issuance
Date”), in connection with the offering pursuant to the Subscription Agreement in the aggregate principal amount of up to
$1,000,000 (the “Note Offering”). The Company and the Holder are sometimes referred to individually, as a “Party”
and collectively, as the “Parties.”

 

NOW THEREFORE, for
good and valuable consideration, the receipt of which is hereby acknowledged, the Parties agree as follows:

 

Section 1. The
Note:

 

1.1 This
Note in the principal amount of $____________ (the “Principal”) is being issued to the Holder pursuant to the Subscription
Agreement between the Company and the Holder dated ___________, 2018.

 

1.2 This
Note is being issued in a transaction exempt from registration under the Securities Act of 1933, as
amended (the “Act”), based upon Regulation D promulgated by the United States Securities and Exchange Commission (the
“SEC”) under the Act. under the Securities Act of 1933, as amended (the “Act”). 

 

1.3 The
Holder hereby represents to the Company that the Holder is an “accredited investor” as that term is defined in Rule
501 of Regulation D.

 

1.4 The
Holder acknowledges and agrees that pursuant to the terms of the above-referenced Subscription Agreement that this Note:
(i) bears interest at the rate of 8% per annum (the “Interest”); (ii) is due and payable on a date twelve (12) months
from the Issuance Date (the “Maturity Date”); and (iii) the Interest and principal amount of this Note payable to Holder
is convertible, on a mandatory basis into shares of the Company’s common stock (the “Shares”) within ten (10)
business days of the effective date of the Reverse Split (the Mandatory Conversion”) as more fully-described in the Subscription
Agreement, at a conversion price of $1.00 per Share (the “Conversion Price”).

 

1.5 This
Note is one of a series of Notes containing substantially identical terms and conditions issued to other accredited holders each
of whom acquired a portion of the Assigned Notes from the Original Noteholders.

 

Section 2. Interest, Maturity Date, Prepayment and
Default:

 

2.1 Interest shall accrue from the
Issuance Date on the unpaid Principal amount at a rate equal to eight (8%) percent per annum, simple interest.

 

2.2 Subject
to Section 2, Principal and any accrued but unpaid Interest under this Note shall be due and payable upon demand by the Holder
at the Maturity Date, unless the Note has been converted into Shares based upon the Mandatory Conversion provisions of Note and
all of the Notes issued pursuant to the separate Subscription Agreements with other Holders, within ten (10) days of the Reverse
Split referenced in Section 1.4 above, which is subject to application with and approval by FINRA and upon the effective date of
the Reverse Split, FINRA.

 

     

     

    

 

2.3 The
Company may prepay the Principal and Interest due on this Note provided that the Company delivers twenty (20) days advance written
notice of the Holder (the “Prepayment Notice”).

 

2.4 Notwithstanding
the provisions of Section 2.2 above, the entire unpaid Principal sum of this Note, together with accrued and unpaid Interest thereon,
unless the same shall be converted into Shares based upon the Mandatory Conversion, shall become immediately due and payable upon:
(i) the execution by the Company of a general assignment for the benefit of creditors; (ii) the filing by or against the Company
of a petition in bankruptcy or any petition for relief under the federal bankruptcy act or the continuation of such petition without
dismissal for a period of 90 days or more; or (iii) the appointment of a receiver or trustee to take possession of the property
or assets of the Company.

 

2.5 Notwithstanding
the provisions of Sections 2.2 through 2.4 above, the Holder, at any time after the Issuance Date or prior to the expiration of
the twenty (20) day period following which the Company has given Holder the Prepayment Notice, may, at Holder’s sole discretion,
elect to convert the entire unpaid Principal together with accrued and unpaid Interest thereon, into Shares at the Conversion
Price set forth in Section 1.4 above, in accordance with the procedures of Section 3 below.

 

Section 3. Conversion: 

 

3.1 The Principal
and accrued but unpaid Interest under this Note shall, at the Holder’s election, may be converted at any time after the Issuance
Date and prior to any prepayment pursuant to Section 2.3 above, into Shares of the Company’s common stock at a Conversion
Price of $1.00 per Share, by delivery of written notice of election to convert (the “Conversion Notice”), in the form
attached as Exhibit A hereto (the “Voluntary Conversion”).

 

3.2 The
Principal and accrued but unpaid Interest under this Note shall be subject to Mandatory Conversion within ten (10) business days
of the effective date of the Reverse Split at the Conversion Price of $1.00 per Share. The Parties acknowledge and agree that the
Reverse Split is subject to approval by FINRA.

 

3.3 No
fractional Shares will be issued upon conversion of this Note. In lieu of any fractional share to which the Holder would otherwise
be entitled, round up the number of Shares issuable to the next whole integer. Upon conversion of this Note pursuant to this Sections
3.2 or 3.3 above, the Holder shall surrender this Note, duly endorsed, at the principal offices of the Company or the transfer
agent of the Company, Empire Stock Transfer or any successor transfer agent (the “Transfer Agent”).

 

3.4 At
its expense, the Company will issue written instructions to Transfer Agent within three (3) business days of receipt of the Conversion
Notice, together with payment by wire transfer to the Company’s bank account as set forth in Section 3.5 below, to issue
and deliver to such Holder, at the address of the Holder most recently furnished in writing to the Company, a certificate or certificates
for the number of Shares to which such Holder is entitled upon such conversion, which Shares shall be issued in book entry form.
Upon conversion of this Note, the Company will be forever released from all of its obligations and liabilities under this Note
with regard to that portion of the Principal and accrued Interest being converted, including, without limitation, the obligation
to pay such portion of the principal amount and accrued interest.

 

3.5 The
wire instructions for payment of the Conversion Price multiplied by the number of Shares being issued are as follows:

 

	Bank:	Bank of America
	ABA:	026009593
	Address:	505 East Market St., Leesburg, VA 20176
	for credit to:	Quantum Computing, Inc.
	Account#:	4350-4394-1694

  

3.6 All
payments shall be made in lawful money of the United States of America by wire transfer to the account set forth in Section 3.5
above.

 

    2

     

    

 

Section 4. Transfer; Successors and
Assigns:  

 

The terms and conditions of this Note shall
inure to the benefit of and be binding upon the respective successors and assigns of the Parties. Notwithstanding the foregoing,
except for a pledge of this Note to a bank or other financial institution that creates a mere security interest in this Note in
connection with a bona fide loan transaction, the Holder may not assign, pledge, or otherwise transfer this Note without the prior
written consent of the Company. Subject to the preceding sentence, this Note may be transferred only upon surrender of the original
Note to the Company for registration of transfer, duly endorsed, or accompanied by a duly executed written instrument of transfer
in form satisfactory to the Company, and, thereupon, a new note for the same principal amount and interest will be issued to, and
registered in the name of, the transferee. Interest and principal are payable only to the registered holder of this Note.

 

Section 5. Governing Law; Jurisdiction: 

 

This Note shall be governed by and construed
under the laws of the State of Virginia, where the Company maintains its offices and banking relationships, among other relevant
contacts, without giving effect to principles of conflicts of law. The Parties irrevocably consent to the jurisdiction and venue
of the state and federal courts located in Fairfax County, State of Virginia, in connection with any action relating to this Note.

 

Section 6. Notices:

 

Any notice required or permitted by this
Note shall be given in writing and shall be deemed effectively given (a) upon personal delivery to the Party to be notified, (b)
upon confirmation of receipt by fax by the Party to be notified, (c) one business day after deposit with a reputable overnight
courier, prepaid for overnight delivery and addressed as set forth in (d), or (d) three days after deposit with the United States
Post Office, postage prepaid, registered or certified with return receipt requested and addressed to the Party to be notified at
the address of such Party indicated on the signature page hereof, or at such other address as such Party may designate by 10 days’
advance written notice to the other Party given in the foregoing manner.

 

 Section 7. Amendments and Waivers:

 

Any term of this Note may be amended only
with the written consent of the Company and the holders of a majority in interest of the Notes. Any amendment or waiver effected
in accordance with this Section 7 shall be binding upon the Company, each Holder and each transferee of the Note.

 

Section 8. Shareholders, Officers and Directors Not
Liable: 

 

In no event shall any shareholder, officer
or director of the Company be liable for any amounts due or payable pursuant to this Note.

 

Section 9. Action to Collect on Note:

 

If
action at law or equity is necessary to enforce or interpret the terms of this Note, the prevailing Party shall be entitled to
reasonable attorney’s fees, costs and necessary disbursements in addition to any other relief to which such Party may be
entitled.

 

Section 10. Waiver of Jury Trial:

 

Each of the
Company and Holder hereby waives its right to trial by jury in any claim (whether based upon contract, tort or otherwise) under,
related to or arising in connection with this Note.

 

    3

     

    

 

Section 11. Waiver of Notice of
Presentment:

 

The Company
hereby waives presentment, protest and demand, notice of protest, demand and dishonor and non-payment of this Note in connection
with the delivery, acceptance, performance, default or enforcement of the payment of this Note.

 

QUANTUM COMPUTING INC/

 

By: _________________________

Name: Robert Liscouski

Title: Chief Executive Officer

 

AGREED TO AND ACCEPTED

BY HOLDER:

 

By: ___________________________

Name: ________________________

Title (if applicable): _____________

Address: ___________________________

___________________________________

___________________________________

Email: _____________________________

Tax ID (if applicable):________________

 

    4

     

    

 

EXHIBIT A

CONVERSION NOTICE

 

The undersigned Holder
hereby elects to convert the principal together with all accrued but unpaid interest hereon under this Convertible Note due _________
__, 2019 of Quantum Computing Inc., a Delaware corporation (the “Company”), into shares of the Company’s common
stock (the “Shares”) according to the conditions hereof, as of the date written below. If the Shares are to be issued
in the name of a person other than the undersigned Holder, the undersigned Holder will pay all transfer taxes, payable with respect
thereto and is delivering herewith such certificates and opinions as reasonably requested by the Company in accordance therewith.
No fee will be charged to the Holder for any conversion, except for such transfer taxes, if any.

 

Conversion Calculations:

 

Date to Effect Conversion: ____________________________

 

Principal Amount of Note to be Converted: $__________________

 

Additional Interest to be Converted: $_______________

 

Number of shares of Common Stock to be issued: ______________

 

Signature: _________________________________________

 

Name: ____________________________________________

 

Address for Delivery of Common Stock Certificates: __________

_____________________________________________________

_____________________________________________________

 

Or

 

DWAC Instructions: _________________________________

 

Broker No: _____________

Account No: _______________

 

    5Exhibit 10.1

 

QUANTUM COMPUTING INC.

215 Depot Court, SE

Leesburg, VA 20175

 

EMPLOYMENT AGREEMENT

 

THIS EMPLOYMENT AGREEMENT (the “Agreement”)
is made as of this 15th day of February 2018, between Robert Liscouski (“Executive”) and Quantum Computing Inc. (the
“Company”), a Delaware corporation.

 

WHEREAS, the Company desires that for the
foreseeable future the Executive will serve as the Company’s President as well as a member of the Board of Directors and
the Executive is willing to continue to serve in the foregoing positions on the terms and conditions set forth in this Agreement;

 

NOW, THEREFORE in consideration of the
mutual covenants and promises contained herein and other good and valuable considerations, the sufficiency of which is hereby acknowledged,
the Company and the Executive hereby agree as follows:

 

1. Effective Date and Term of Employment.
As of the first date stated above (“Effective Date”), the Executive shall serve as the Company’s President and
Chief Executive Officer (“CEO”). The Company will employ Executive as President and CEO, and Executive agrees to work
for the Company, at its Leesburg, Virginia facility, to perform the duties and responsibilities inherent in such position, and
such other duties and responsibilities as the Company shall from time to time assign to Executive.

 

2. Duties and Responsibilities.
The Executive agrees to work for the Company as its President performing all of the duties and responsibilities inherent in such
position. As the President the Executive shall report to the Company’s Board of Directors and shall be subject to the supervision
thereof, and Executive shall have such authority as is delegated by the Board, which authority shall be sufficient for Executive
to perform all of the duties of the office referenced herein. The Executive shall devote the Executive’s full business time
and reasonable best efforts in the performance of the foregoing services. Subject to the restrictions set forth in Section 6.4,
Executive may accept other board memberships or service with other charitable organizations that are not in conflict with Executive’s
primary responsibilities and obligations to the Company.

 

3. Compensation and Benefits.

 

3.1 Salary.
The Company has paid, prior to the Effective Date hereof, and shall continue to pay, Executive a base salary of $15,000.00
twice per calendar month (i.e., at an annualized rate of $360,000 per year), payable in accordance with the Company’s
customary payroll practices (the “Base Salary”). The Base Salary thereafter shall be subject to annual review and
adjustment, as determined by the Board (or the Compensation Committee of the Board) in its sole discretion, provided,
however, that the Base Salary may not be decreased without the Executive’s consent unless the compensation payable to
all executives of the Company is also similarly reduced.

 

     

     

    

 

3.2 Annual
Incentive. For the fiscal year ending December 31, 2019 and in subsequent fiscal years, Executive will be eligible to
receive an annual cash bonus in an amount up to $150,000, subject to Executive achieving the performance milestones that are
established and approved by the Board of Directors within 60 days following the beginning of such fiscal year. The bonus, if
payable, shall be calculated and paid within 30 days after the end of the fiscal year in which such bonus was earned; provided, however,
that the Company may delay the calculation and payment of any portion of such bonus which is based on the attainment of a
revenue, earnings or similar milestone until the completion of the audit of the Company’s financial statements for the
fiscal year in question. {I am not sure we want to start this until the company is generating revenue}

 

3.3 Long-Term Incentives. The Company
may from time to time establish incentive programs, including but not limited to stock options, and the Executive will be eligible
to participate in such incentive programs under terms to be set when such programs are approved by the Board and Shareholders.

 

3.4 Fringe Benefits. Executive shall
be entitled to participate in all bonus and benefit programs that the Company establishes and makes available to its executive
employees, if any, to the extent that Executive’s position, tenure, salary, age, health and other qualifications make Executive
eligible to participate, including, but not limited to health care plans, short and long term disabilities plans, life insurance
plans, retirement plans, and all other benefit plans from time to time in effect. Executive shall also be entitled to take four
(4) weeks of fully paid vacation in accordance with Company policy.

 

3.5 Reimbursement
of Certain Expenses. Executive shall be reimbursed for such reasonable and necessary business expenses incurred by
Executive while Executive is employed by the Company, which are directly related to the furtherance of the Company’s
business, including compensation under the Company’s standard policies if Executive uses his personal vehicle for
Company business where such business is more than one hundred fifty (150) miles from the Company’s main offices or
Executive’s home, wherever such trip commences. The Executive must submit any request for reimbursement no later than
fifteen (15) days following the date that such business expense is incurred in accordance with the Company’s
reimbursement policy regarding same and business expenses must be substantiated by appropriate receipts and documentation.
The Company may request additional documentation or a further explanation to substantiate any business expense submitted for
reimbursement, and retains the discretion to approve or deny a request for reimbursement. If a business expense reimbursement
is not exempt from Section 409A of the Code, any reimbursement in one calendar year shall not affect the amount that may be
reimbursed in any other calendar year and a reimbursement (or right thereto) may not be exchanged or liquidated for
another benefit or payment. Any business expense reimbursements subject to Section 409A of the Code shall be made no later
than the end of the calendar year following the calendar year in which such business expense is incurred by the
Executive.

 

3.6 Indemnification. The Company
shall continue to indemnify Executive to the fullest extent permitted under applicable law, the Company’s Articles of Organization
and the Company’s By-laws, each as they may be amended from time to time. The Executive shall be insured under the Company’s
Directors’ and Officers’ liability policy in the same manner as other senior executives of the Company for as long
as Executive is an officer or director of the Company and as long as the Company maintains such policy in force. Such indemnity
and insurance shall survive the termination of Executive’s employment by the Company.

 

    2

     

    

 

4. Termination of Employment Period.
Executive’s employment under the terms of this agreement may terminate upon the occurrence of any of the following:

 

4.1 Termination
for Cause. At the election of the Company, for “Cause,” upon written notice by the Company to Executive. For
the purposes of this Section, “Cause” for termination shall be deemed to exist upon the occurrence of any of the
following:

 

(a) Executive’s conviction or entry
of nolo contendere to any felony or a crime involving moral turpitude, fraud or embezzlement of Company property; or

 

(b) Executive’s dishonesty, gross
negligence or gross misconduct that is materially injurious to the Company or material failure to perform her/his duties under
this Agreement which has not been cured by Executive within 10 days after he/she shall have received written notice from the Company
stating with reasonable specificity the nature of such failure to perform; or

 

(c) Executive’s illegal use or abuse
of drugs, alcohol, or other related substances that is materially injurious to the Company.

 

4.2 Voluntary Termination
by the Company. At the election of the Company, without Cause.

 

4.3 Death or Disability.
Upon the death or disability of Executive. As used in this Agreement, “disability” shall occur when Executive, due
to a physical or mental disability, for a period of 90 days in the aggregate whether or not consecutive, during any 360-day period,
is unable to perform the services contemplated under this Agreement.

 

4.4 Termination for
Good Reason. Subject to the notice and cure periods set forth in Section 5.5, at the election of Executive for “Good
Reason” (as defined below), upon written notice by the Executive to the Company.

 

4.5 Voluntary Termination by Executive. At the election
of Executive, without. Good Reason, upon not less than 30 days prior written notice by him/her to the Company.

 

5. Effect of Termination.

 

5.1 Termination for Cause, at the Election
of Executive, or at Death or Disability. In the event that Executive’s employment is terminated for Cause, the Company
shall have no further obligations under this Agreement other than to pay to Executive Base Salary and accrued vacation through
the last day of Executive’s actual employment by the Company. In the event that Executive’s employment is terminated
upon Executive’s death or disability, or at the election of Executive, the Company shall have no further obligations under
this Agreement other than (i) to pay to Executive, in a single lump sum upon such termination, Base Salary and accrued vacation
through the last day of Executive’s actual employment by the Company and (ii) to pay to Executive, in a single lump sum,
pro rata portion of any bonus (to the extent earned prior to such termination) for the fiscal year in which termination occurs,
pursuant to Section 3.2.

 

    3

     

    

 

5.2 Voluntary Termination by the Company,
or for Good Reason. In the event that Executive’s employment is terminated during the term of this Agreement without
Cause, or by Executive’s resignation for Good Reason, and Executive executes a release in favor of the Company substantially
in the form annexed hereto as Exhibit A, not later than 30 days after Executive’s employment terminates, and the period in
which Executive is entitled to revoke such release has expired without any such revocation, then the Company shall continue to
pay to Executive the annual Base Salary in effect immediately prior to such termination for the twelve-month period following Executive’s
last day of employment. In addition, the Company shall continue Executive’s coverage under and its contributions towards
Executive’s health care, dental, and life insurance benefits on the same basis as immediately prior to the date of termination,
except as provided below, for the six-month period following Executive’s last day of employment. In addition to the foregoing
amounts, the Company shall pay Executive in a single lump sum, a pro rata portion of any bonus (to the extent earned prior to such
termination) for the year in which termination occurs, pursuant to Section 3.2. Notwithstanding the foregoing, subject to any overriding
laws, the Company shall not be required to provide any health care, dental, or life insurance benefit otherwise receivable by Executive
if Executive is actually covered or becomes covered by an equivalent benefit (at the same cost to Executive, if any) from another
source. Any such benefit made available to Executive shall be reported to the Company.

 

5.3 Notwithstanding any other provision
of this Amended Agreement with respect to the timing of payments under Section 5, if, at the time of the Executive’s termination,
the Executive is deemed to be a “specified employee” of the Company within the meaning of Section 409A(a)(2)(B)(i)
of the Code, then only to the extent necessary to comply with the requirements of Section 409A of the Code, any payments to which
the Executive may become entitled under Section 5 which are subject to Section 409A of the Code (and not otherwise exempt from
its application) will be withheld until the first business day of the seventh month following the date of termination, at which
time the Executive shall be paid an aggregate amount equal to six months of payments otherwise due to the Executive under the terms
of Section 5, as applicable. After the first business day of the seventh month following the date of termination and continuing
each month thereafter, the Executive shall be paid the regular payments otherwise due to the Executive in accordance with the terms
of Section 5, as thereafter applicable.

 

5.4 Upon Executive’s termination
without Cause during the term of this Agreement, or as a result of Executive’s resignation for Good Reason during the term
of this Agreement, all stock options granted by the Company and then held by Executive shall be accelerated and become fully vested
and exercisable as of the date of Executive’s termination.

 

    4

     

    

 

5.5 As used in this
Agreement, “Good Reason” means, without Executive’s written consent, (a) a “material
diminution” (as such term is used in Section 409A of the Code) of the duties assigned to Executive (provided, however,
that no termination of Executive’s service as a member of the Board, regardless of the reason therefore, shall
constitute a “material diminution” of Executive’s duties for purposes of this Section 5.5); or (b) a
material reduction in Base Salary or other benefits (other than a reduction or change in benefits generally applicable to all
executive employees of the Company); or (c) relocation to an office more than 50 miles further from Executives current
residence in Virginia than the Company’s current location in the greater Washington, DC metropolitan area is located
from such residence; or (d) a “Change of Control” of the Company, as that term is defined in the Control Plan; or
(e), the acquisition (other than an acquisition directly from the Company) by any individual, entity or group (within the
meaning of Section 13(d)(3) or 14(d)(2) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)),
of beneficial ownership (within the meaning of Rule 13d-3 promulgated under the Exchange Act) of 50% or more of the then
outstanding shares of voting stock of the Company (the “Voting Stock”); provided, however, that any
acquisition by the Company or its subsidiaries, or any employee benefit plan (or related trust) of the Company or its
subsidiaries of (i) 50% or more of the then outstanding Voting Stock, or (ii) Voting Stock which has the effect of increasing
the percentage of Voting Stock owned by any such individual, entity or group to 50% or more of the then outstanding Voting
Stock, shall not constitute a Change of Control. In the event Executive resigns for Good Reason within twelve (12) months
after a Change of Control or acquisition, as defined in (d) or (e) above, Executive shall receive, in addition to any
severance to which he/she is entitled under § 5.2 of the Employment Agreement as amended, an additional sum equal to
twelve (12) months of his/her base salary then in effect. Notwithstanding the occurrence of any of the events enumerated in
this Section 5.5, no event or condition shall be deemed to constitute Good Reason unless (i) Executive reports the event or
condition which the Executive believes to be Good Reason to the Board, in writing, within 45 days of such event or condition
occurring and (ii) within 30 days after the Executive provides such written notice of Good Reason, the Company has failed to
fully correct such Good Reason and to make the Executive whole for any such losses.

 

5.6 The provisions of this Section 5 and
the payments provided hereunder are intended to be exempt from or to comply with the requirements of Section 409A of the Code,
and shall be interpreted and administered consistent with such intent. To the extent required for compliance with Section 409A,
references in this Agreement to a “termination of employment” shall mean a “separation of service” as defined
by Section 409A. It is further intended that each installment of the payments provided hereunder shall be treated as a separate
“payment” for purposes of Section 409A. Neither the Company nor Executive shall have the right to accelerate or defer
the delivery of any such payments or benefits except to the extent specifically permitted or required by Section 409A.

 

6. Nondisclosure and Noncompetition.

 

6.1 Proprietary Information.

 

(a) Executive agrees that all information
and know-how, whether or not in writing, of a private, secret or confidential nature concerning the Company’s business or
financial affairs (collectively, “Proprietary Information”) is and shall be the exclusive property of the Company.
By way of illustration, but not limitation, Proprietary Information may include inventions, products, processes, methods, techniques,
formulas, designs, drawings, slogans, tests, logos, ideas, practices, projects, developments, plans, research data, financial data,
personnel data, computer programs and codes, and customer and supplier lists. Executive will not disclose any Proprietary Information
to others outside the Company except in the performance of his/her duties or use the same for any unauthorized purposes without
written approval by an officer of the Company, either during or after his employment, unless and until such Proprietary Information
has become public knowledge or generally known within the industry without fault by Executive, or unless otherwise required by
law.

 

    5

     

    

 

(b) Executive agrees that all files, letters,
memoranda, reports, records, data, sketches, drawings, laboratory notebooks, program listings, or other written, photographic,
electronic or other material containing Proprietary Information, whether created by Executive or others, which shall come into
his custody or possession, shall be and are the exclusive property of the Company to be used by Executive only in the performance
of her/his duties for the Company.

 

(c) Executive agrees that his/her obligation
not to disclose or use information, know-how and records of the types set forth in paragraphs (a) and (b) above, also extends
to such types of information, know-how, records and tangible property of subsidiaries and joint ventures of the Company, customers
of the Company or suppliers to the Company or other third parties who may have disclosed or entrusted the same to the Company or
to Executive in the course of the Company’s business.

 

6.2 Inventions.

 

(a) Disclosure. Executive shall
disclose promptly to an officer or to attorneys of the Company in writing any idea, invention, work of authorship, whether patentable
or un-patentable, copyrightable or un-copyrightable, including, but not limited to, any computer program, software, command structure,
code, documentation, compound, genetic or biological material, formula, manual, device, improvement, method, process, discovery,
concept, algorithm, development, secret process, machine or contribution (any of the foregoing items hereinafter referred to as
an “Invention”) Executive may conceive, make, develop or work on, in whole or in part, solely or jointly with others.
The disclosure required by this Section applies (a) to any invention related to the general line of business engaged in by the
Company or to which the Company planned to enter during the period of Executive’s employment with the Company and for one
year thereafter; (b) with respect to all Inventions whether or not they are conceived, made, developed or worked on by Executive
during Executive’s regular hours of employment with the Company; (c) whether or not the Invention was made at the suggestion
of the Company; and (d) whether or not the Invention was reduced to drawings, written description, documentation, models or other
tangible form.

 

(b) Assignment of inventions to Company Exemption of Certain Inventions. Executive hereby assigns to the Company without royalty or any other further consideration
Executive’s entire right, title and interest in and to all Inventions which Executive conceives, makes, develops or works
on during employment and for one year thereafter, except as limited by 6.2(a) above and those Inventions that Executive develops
entirely on Executive’s own time after the date of this Agreement without using the Company’s equipment, supplies,
facilities or trade secret information unless those Inventions either (a) relate at the time of conception or reduction to practice
of the Invention to the Company’s business, or actual or demonstrably anticipated research or development of the Company;
or (b) result from any work performed by Executive for the Company.

 

    6

     

    

 

(c) Records. Executive will make
and maintain adequate and current written records of all Inventions. These records shall be and remain the property of the Company.

 

(d) Patents. Executive will assist
the Company in obtaining, maintaining and enforcing patents and other proprietary rights in connection with any Invention covered
by Section 6.2. Executive further agrees that his obligations under this Section shall continue beyond the termination of his employment
with the Company, but if he is called upon to render such assistance after the termination of such employment, he shall be entitled
to a fair and reasonable rate of compensation for such assistance. Executive shall, in addition, be entitled to reimbursement of
any expenses incurred at the request of the Company relating to such assistance.

 

6.3
Prior Contracts and Inventions Information Belonging to Third Parties. Executive represents that there are no contracts
to assign Inventions between any other person or entity and Executive. Executive further represents that (a) Executive is not
obligated under any consulting, employment or other agreement which would
affect the Company’s rights or my duties under this Agreement, (b) there is no action, investigation, or proceeding pending
or threatened, or any basis therefor known to me involving Executive’s prior employment or any consultancy or the use of
any information or techniques alleged to be proprietary to any former employer, and (c) the performance of Executive’s duties
as an employee of the Company will not breach, or constitute a default under any agreement to which Executive is bound, including,
without limitation, any agreement limiting the use or disclosure of proprietary information acquired in confidence prior to engagement
by the Company. Executive will not, in connection with Executive’s employment by the Company, use or disclose to the Company
any confidential, trade secret or other proprietary information of any previous employer or other person to which Executive is
not lawfully entitled.

 

6.4 Noncompetition
and Non-solicitation.

 

(a) During Executive’s employment with
the Company and for a period of 12 months after the termination of Executive’s employment with the Company for any reason or for
no reason, Executive will not directly or indirectly, absent the Company’s prior written approval, render services of a business,
professional or commercial nature to any other person or entity in the area of quantum computing development or such other services
or products provided by the Company at the time employment terminates in any geographical area where the Company does business
at the time this covenant is in effect, whether such services are for compensation or otherwise, whether alone or in conjunction
with others, as an employee, as a partner, or as a shareholder (other than as the holder of not more than 1% of the combined voting
power of the outstanding stock of a public company), officer or director of any corporation or other business entity, or as a trustee, fiduciary or in any other similar representative capacity.

 

    7

     

    

 

(b) During the Executive’s employment with
the Company and for a period of 12 months after the termination of Executive’s employment for any reason or for no reason, Executive
will not, directly or indirectly, recruit, solicit or induce, or attempt to recruit, solicit or induce any employee or employees
of the Company to terminate their employment with, or otherwise cease their relationship with, the Company.

 

(c) During the Executive’s employment with
the Company and for a period of 12 months after termination of
Executive’s employment for any reason or for no reason, Executive will not, directly or indirectly, contact, solicit, divert or
take away, or attempt to solicit, contact, divert or take away, the business or patronage of any of the clients, customers or accounts,
or prospective clients, customers or accounts, of the Company.

 

6.5 Interpretation of Agreement. If any restriction set forth in this Section is found by any court of competent jurisdiction to be unenforceable
because it extends for too long a period of time or over too great a range of activities or in too broad a geographic area, it
shall be interpreted to extend only over the maximum period of time, range of activities or geographic area as to which it may
be enforceable.

 

6.6 Restrictions Necessary. The restrictions contained in this Section are necessary for the protection of the business, proprietary information,
and goodwill of the Company and are considered by Executive to be reasonable for such purpose. Executive agrees that any breach
of this Section will cause the Company substantial and irrevocable damage and therefore, in the event of any such breach, in
addition to such other remedies which may be available, the Company shall have the right to seek specific performance and
injunctive relief. The prevailing party shall be entitled to recover its reasonable attorneys’ fees in such an action. In
addition, the Company’s obligation to pay Executive the amount set forth in Section 5.2 or 5.3 shall terminate in the event
Executive materially breaches any terms and conditions in Section 6.

 

7. Entire Agreement.
This Agreement constitutes the entire agreement between the parties and supersedes all prior agreements and understandings, whether
written or oral relating to the subject matter of this Agreement between the
Company and the Executive. For the avoidance of doubt, however, this Agreement is in addition to, and shall not supersede
any stock option agreement between the Company and Executive.

 

8. Amendment.
This Agreement may be amended or modified only by a written instrument executed by both the Company and Executive.

 

9. Arbitration.
All disputes concerning compliance with or the interpretation of this Agreement, or any other aspect of Executive’s employment
with the Company or the termination of that employment, shall be resolved by a single arbitrator under the Employment Dispute
Rules then obtaining of the American Arbitration Association. The decision of the arbitrator shall be final and binding. Notwithstanding
the foregoing, any claims by the Company concerning Executive’s compliance with the Nondisclosure and Noncompetition provisions
of this Agreement are excluded from the scope of this Arbitration provision and may be brought in any court of competent jurisdiction.
This Agreement shall be construed, interpreted and enforced in accordance with the laws of the Commonwealth of Virginia without
regard to principles of conflicts of laws thereunder.

 

    8

     

    

 

10. Notices.
Any notice or other communication required or permitted by this Agreement to be given to a party shall be in writing and shall
be deemed given if delivered personally or by commercial messenger or courier service, or mailed by U.S. registered or certified
mail (return receipt requested), or sent via facsimile (with receipt of confirmation of complete transmission) to the party at
the party’s last known address or facsimile number or at such other address or facsimile number as the party may have previously
specified by like notice. If by mail, delivery shall be deemed effective three business days after mailing in accordance with
this Section.

 

11. Successors
and Assigns. This Agreement shall be binding upon and inure to the benefit of both parties and their respective successors
and assigns, including any corporation into which the Company may be merged or which may succeed to its assets or business, provided,
however, that the obligations of Executive are personal and shall not be assigned by her/him.

 

12. Miscellaneous.

 

12.1 No Waiver.
No delay or omission by the Company in exercising any right under this Agreement shall operate as a waiver of that or any other
right. A waiver or consent given by the Company on any one occasion shall be effective only in that instance and shall not be
construed as a bar or waiver of any right on any other occasion.

 

12.2 Severability.
In case any provision of this Agreement shall be invalid, illegal or otherwise unenforceable, the validity, legality and enforceability
of the remaining provisions shall in no way be affected or impaired thereby.

 

12.3 Counterparts.
This Agreement may be executed in two or more counterparts, each of which shall be deemed an original but all of which together
shall constitute one and the same instrument and facsimile signatures delivered by fax or e-mail transmission shall be treated
as originals.

 

[Signature page follows]

 

    9

     

    

 

IN WITNESS WHEREOF, each of the
Company and Executive has executed this Amendment as of the date first above written.

 

	 	QUANTUM
    COMPUTING INC.
	 	 	 	 
	 	By:	/s/ Christopher Roberts
	 	 	Name:	Christopher Roberts
	 	 	Title:	Chief Financial Officer
	 	 	 	 
	 	Date Executed: March 1, 2018

 

	 	/s/ Robert Liscouski
	 	Robert Liscouski
	 	 
	 	Date Executed: March 1, 2018

 

[Signature page for employment agreement]

 

    10

     

    

 

Exhibit A

 

General Release of Claims

 

1.
Your Release of Claims. By signing this Agreement, you hereby agree and acknowledge that, for good and
valuable consideration, you are waiving your right to assert any and all forms of legal claims against the Company1/
of any kind whatsoever, whether known or unknown,
arising from the beginning of time through the date you execute this Agreement (the “Execution Date”). Except as set
forth below, your waiver and release herein is intended to bar any form of legal claim, complaint or any other form of action
(jointly referred to as “Claims”) against the Company seeking any form of relief including, without limitation, equitable
relief (whether declaratory, injunctive or otherwise), the recovery of any damages, or any other form of monetary recovery whatsoever
(including, without limitation, back pay, front pay, compensatory damages, emotional distress damages, punitive damages, attorneys’
fees and any other costs) against the Company, for any alleged action, inaction or circumstance existing or arising through the
Execution Date.

 

Without limiting the foregoing general
waiver and release, you specifically waive and release the Company from any Claim arising from or related to your prior employment
relationship with the Company or the termination thereof, including, without limitation:

 

		**	Claims under any state or
federal discrimination, fair employment practices or other employment related statute, regulation or executive order (as they
may have been amended through the Execution Date) prohibiting discrimination or harassment based upon any protected status including,
without limitation, race, national origin, age, gender, marital status, disability, veteran status or sexual orientation. Without
limitation, specifically included in this paragraph are any Claims arising under the Age Discrimination in Employment Act, Title
VII of the Civil Rights Act of 1964, the Civil Rights Act of 1991, the Equal Pay Act, the Americans With Disabilities Act and
any similar Federal and state statute.

 

		**	Claims under any other state
or federal employment related statute, regulation or executive order (as they may have been amended through the Execution Date)
relating to wages, hours or any other terms and conditions of employment.

 

		**	Claims under any state or
federal common law theory including, without limitation, wrongful discharge, breach of express or implied contract, promissory
estoppel, unjust enrichment, breach of a covenant of good faith and fair dealing, violation of public policy, defamation, interference
with contractual relations, intentional or negligent infliction of emotional
distress, invasion of privacy, misrepresentation, deceit, fraud or negligence.

 

		**	Any
other Claim arising under state or federal law.

 

 

		1/	For purposes of this Agreement,
the Company includes the Company and any of its divisions, affiliates (which means all
persons and entities directly or indirectly controlling, controlled by or under common control with the Company), subsidiaries
and all other related entities, and its and their directors, officers,
employees, trustees, agents, successors and assigns.

 

    11

     

    

 

You acknowledge and agree that, but for
providing this waiver and release, you would not be receiving the economic benefits being provided to you under the terms of this
Agreement. You further acknowledge that this release does not waive any claims you cannot by law waive and does not release any
claims that arise after its execution.

 

It is the Company’s desire and intent to
make certain that you fully understand the provisions and effects of this Agreement. To that end, you have been advised and given
the opportunity to consult with legal counsel for the purpose of reviewing the terms of this Agreement. Also, because you are over
the age of 40, the Age Discrimination in Employment Act (“ADEA”), which prohibits discrimination on the basis of age, allows
you at least twenty-one (21) days to consider the terms of this Agreement. ADEA also allows you to rescind your assent to this
Agreement if, within seven (7) days after you sign this Agreement, you deliver by hand or send by mail (certified, return receipt
and postmarked within such 7 day period) a notice of rescission to the Company. The eighth day following your signing of this Agreement
is the Effective Date.

 

Also, consistent with the provisions of
Federal law, nothing in this release shall be deemed to prohibit you from challenging the validity of this release under the discrimination
laws (the “Federal Discrimination Laws”) or from filing a charge or complaint of employment-related discrimination with
the Equal Employment Opportunity Commission (“EEOC”) or any state fair employment practices agency, or from participating
in any investigation or proceeding conducted by the EEOC or any state fair employment practices agency. Further, nothing in this
release or Agreement shall be deemed to limit the Company’s right to seek immediate dismissal of such charge or complaint on the
basis that your signing of this Agreement constitutes a full release of any individual rights under the Federal Discrimination
Laws, or to seek restitution to the extent permitted by law of the economic benefits provided to you under this Agreement in the
event that you successfully challenge the validity of this release and prevail in any claim under the Federal Discrimination Laws.

 

	 	By:	 
	 	 	Executive:
	 	 	Date signed: March 1, 2018

 

    12

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00290-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00290-of-00352.parquet"}]]